Jun 18, 2026 8:30 am EDT LIXTE Biotechnology Provides Update on NOMAD Acquisition; Transaction Expected to Close On or About July 1, 2026
Jun 12, 2026 8:30 am EDT LIXTE Biotechnology to Acquire NOMAD Transportable Power Systems, the Market Leader in Mobile, Utility-Grade Battery Energy Storage Systems (BESS)
Jun 3, 2026 8:30 am EDT LIXTE Biotechnology Announces $16,566,027 Registered Direct Offering Priced at the Market Under Nasdaq Rules, Strengthening Balance Sheet for Next Phase of Strategic Growth
Jun 1, 2026 8:50 am EDT LIXTE Biotechnology Announces Strategic Transformation into AI Energy Infrastructure Equipment & Services; Stuart D. Porter, Founder of Denham Capital, to Join Board of Directors
May 14, 2026 5:18 pm EDT LIXTE Biotechnology Files First Quarter 2026 Quarterly Report on Form 10-Q; Provides Operational Progress Update
Apr 13, 2026 8:00 am EDT Favorable Results of Ovarian Cancer Study Presented at Annual Society of Gynecological Care Conference
Mar 31, 2026 3:45 pm EDT LIXTE Biotechnology Files 2025 Annual Report on Form 10K, Provides Operational Highlights of Transformative Year
Feb 18, 2026 8:00 am EST LIXTE Biotechnology Appoints Sidney Braun as CEO of its Liora Technologies Europe Ltd. Subsidiary
Jan 21, 2026 8:00 am EST DE LA SOUL-LED “GOOD HEALTH SUMMIT” LAUNCHES FEBRUARY 19 AT MOREHOUSE COLLEGE
Jan 20, 2026 8:00 am EST LIXTE Biotechnology Attending the DealFlow Discovery Conference, January 28-29
